Page last updated: 2024-08-25

bendamustine hydrochloride and Neoplasms, Otorhinolaryngologic

bendamustine hydrochloride has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bathe, K; Bottke, D; Hinkelbein, W; Wiegel, T	1

Trials

1 trial(s) available for bendamustine hydrochloride and Neoplasms, Otorhinolaryngologic

Article	Year
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2007, Volume: 183, Issue:3 Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Otorhinolaryngologic Neoplasms	2007

Article

Year

Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2007, Volume: 183, Issue:3

Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Otorhinolaryngologic Neoplasms

2007